Mabwell's 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease ...Middle East

SHANGHAI, June 4, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed innovative antibody drug 9MW5211 has received approval from the National Medical Products...

Hence then, the article about mabwell s 9mw5211 receives ind clearance from nmpa for inflammatory bowel disease was published today ( Friday 05/06/2026 - 06:35 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mabwell's 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease )

Also on site :

• Lebanon on fire: Why Israel derailed US-Iran diplomacy
• Sheetz Is Giving Away a Ton of Free 'Top-Selling' Bakery Items Nationwide — Here's How to Claim Yours
• Buffalo Wild Wings Under Fire After Controversial Fan Giveaway Goes Viral